Wearable electrochemical glucose sensors in diabetes management: a comprehensive review

T Saha, R Del Caño, K Mahato, E De la Paz… - Chemical …, 2023 - ACS Publications
With the rising diabetic population, the demand for glucose sensing devices has also been
on an increasing trend. Accordingly, the field of glucose biosensors for diabetes …

Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished …

JZ Goldenberg, A Day, GD Brinkworth, J Sato… - bmj, 2021 - bmj.com
Objective To determine the efficacy and safety of low carbohydrate diets (LCDs) and very
low carbohydrate diets (VLCDs) for people with type 2 diabetes. Design Systematic review …

[PDF][PDF] Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

M Reiterer, M Rajan, N Gómez-Banoy, JD Lau… - Cell metabolism, 2021 - cell.com
Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer
hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and …

[HTML][HTML] The effects of type 2 diabetes mellitus on organ metabolism and the immune system

G Daryabor, MR Atashzar, D Kabelitz, S Meri… - Frontiers in …, 2020 - frontiersin.org
Metabolic abnormalities such as dyslipidemia, hyperinsulinemia, or insulin resistance and
obesity play key roles in the induction and progression of type 2 diabetes mellitus (T2DM) …

Gestational diabetes mellitus

HD McIntyre, P Catalano, C Zhang, G Desoye… - Nature reviews Disease …, 2019 - nature.com
Hyperglycaemia that develops during pregnancy and resolves after birth has been
recognized for over 50 years, but uniform worldwide consensus is lacking about threshold …

[PDF][PDF] The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study

H Wu, V Tremaroli, C Schmidt, A Lundqvist, LM Olsson… - Cell metabolism, 2020 - cell.com
The link between the gut microbiota and type 2 diabetes (T2D) warrants further investigation
because of known confounding effects from antidiabetic treatment. Here, we profiled the gut …

Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control …

SB Solerte, F D'Addio, R Trevisan, E Lovati… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Poor outcomes have been reported in patients with type 2 diabetes and
coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic …

Sulfoximines as rising stars in modern drug discovery? Current status and perspective on an emerging functional group in medicinal chemistry

P Mäder, L Kattner - Journal of Medicinal Chemistry, 2020 - ACS Publications
Sulfoximines have been largely disregarded in medicinal chemistry for a long time.
However, recently, they have risen to the apparent level of stardom on the drug discovery …

Chronic tissue inflammation and metabolic disease

YS Lee, J Olefsky - Genes & development, 2021 - genesdev.cshlp.org
Obesity is the most common cause of insulin resistance, and the current obesity epidemic is
driving a parallel rise in the incidence of T2DM. It is now widely recognized that chronic …

[PDF][PDF] Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity

L Wang, B Wang, NS Gasek, Y Zhou, RL Cohn… - Cell metabolism, 2022 - cell.com
Insulin resistance is a pathological state often associated with obesity, representing a major
risk factor for type 2 diabetes. Limited mechanism-based strategies exist to alleviate insulin …